China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ) soared at $0.29, a gain of 45.4%. The stock got featured on our News Catalysts scanner on Tue, Mar 15, 2022 at 03:13 AM in the 'AGREEMENT' category. From Mon, Mar 14, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Wed, Mar 02, 2022 at $0.32 with a volume of 77M+.
About China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ)
China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Top 10 Gainers:
- IGM Biosciences, Inc. (IGMS:NASDAQ), 96.73%
- PhaseBio Pharmaceuticals, Inc. (PHAS:NASDAQ), 46.09%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 45.4%
- Oblong Inc. (OBLG:NASDAQ), 45%
- Clever Leaves Holdings Inc. (CLVR:NASDAQ), 40.31%
- MicroVision, Inc. (MVIS:NASDAQ), 32.78%
- ECMOHO Limited (MOHO:NASDAQ), 27.95%
- LianBio (LIAN:NASDAQ), 27.5%
- BBQ Holdings, Inc. (DAVE:NASDAQ), 27.45%
- Kinnate Biopharma Inc. (KNTE:NASDAQ), 25.94%